Medicare Retiree Drug Subsidy Tax May Prompt Employer Coverage Shifts, Focus On Rx Costs
This article was originally published in The Pink Sheet Daily
Executive Summary
Employer-sponsored drug coverage for retirees may change in the coming years as a result of the new tax of the Medicare retiree drug subsidy, signed into law as part of health reform.
You may also be interested in...
Part D Retiree Drug Subsidy Tax Likely To Cost Government, Employers Say
Business leaders are intensifying opposition to a provision in the House and Senate health care reform bills that would revise the tax treatment on the Medicare Part D subsidy for employers who provide retirees with prescription drug coverage
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.